178 related articles for article (PubMed ID: 16802536)
1. [Myelodysplastic syndromes--new treatment options].
Germing U
Med Klin (Munich); 2006 Mar; 101 Suppl 1():123-6. PubMed ID: 16802536
[TBL] [Abstract][Full Text] [Related]
2. [Myelodysplastic syndromes. Diagnosis and therapeutic strategies].
Aul C; Giagounidis A; Germing U; Ganser A
Med Klin (Munich); 2002 Nov; 97(11):666-76. PubMed ID: 12434275
[TBL] [Abstract][Full Text] [Related]
3. Treatment strategies and issues in low/intermediate-1-risk myelodysplastic syndrome (MDS) patients.
Bowen DT
Semin Oncol; 2005 Aug; 32(4 Suppl 5):S16-23. PubMed ID: 16085013
[TBL] [Abstract][Full Text] [Related]
4. Advances in supportive care of myelodysplastic syndromes.
Gordon MS
Semin Hematol; 1999 Oct; 36(4 Suppl 6):21-4. PubMed ID: 10530713
[TBL] [Abstract][Full Text] [Related]
5. [The myelodysplastic syndrome II. New therapeutic principles, course and prognosis].
Hasselbalch HC; Juhl BR; Hansen PB
Ugeskr Laeger; 2002 Jan; 164(4):479-82. PubMed ID: 11838418
[TBL] [Abstract][Full Text] [Related]
6. Treatment of adult myelodysplastic syndromes.
Hellström-Lindberg E
Int J Hematol; 1999 Oct; 70(3):141-54. PubMed ID: 10561906
[TBL] [Abstract][Full Text] [Related]
7. Is International Prognostic Scoring System (IPSS) still standard in predicting prognosis in patients with myelodysplastic syndrome? External validation of the WHO Classification-Based Prognostic Scoring System (WPSS) and comparison with IPSS.
Park MJ; Kim HJ; Kim SH; Kim DH; Kim SJ; Jang JH; Kim K; Kim WS; Jung CW
Eur J Haematol; 2008 Nov; 81(5):364-73. PubMed ID: 18637029
[TBL] [Abstract][Full Text] [Related]
8. [Myelodysplastic syndrome--classification, prognosis and therapy].
Cermák J; Michalová K; Vítek A
Cas Lek Cesk; 2002 Sep; 141 Suppl():33-7. PubMed ID: 12428420
[TBL] [Abstract][Full Text] [Related]
9. [Myelodysplastic syndrome].
Urabe A
Gan To Kagaku Ryoho; 2005 Mar; 32(3):287-91. PubMed ID: 15791810
[TBL] [Abstract][Full Text] [Related]
10. [Myeloproliferative syndromes].
Ganser A
Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
[TBL] [Abstract][Full Text] [Related]
11. Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Semin Hematol; 2008 Jan; 45(1):14-22. PubMed ID: 18179965
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making.
Malcovati L; Porta MG; Pascutto C; Invernizzi R; Boni M; Travaglino E; Passamonti F; Arcaini L; Maffioli M; Bernasconi P; Lazzarino M; Cazzola M
J Clin Oncol; 2005 Oct; 23(30):7594-603. PubMed ID: 16186598
[TBL] [Abstract][Full Text] [Related]
13. Update on the therapy for myelodysplastic syndrome.
Kasner MT; Luger SM
Am J Hematol; 2009 Mar; 84(3):177-86. PubMed ID: 19195035
[TBL] [Abstract][Full Text] [Related]
14. Managing patients with low-risk MDS.
Sekeres M; Cosgrove D; Falco A
Clin Adv Hematol Oncol; 2006 Jul; 4(7 Suppl 16):1-10; quiz 11-2. PubMed ID: 17139240
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplasia: when to treat and how.
Larson RA
Best Pract Res Clin Haematol; 2006; 19(2):293-300. PubMed ID: 16516126
[TBL] [Abstract][Full Text] [Related]
16. Treatment with growth factors in myelodysplastic syndromes.
Geissler RG; Schulte P; Ganser A
Pathol Biol (Paris); 1997 Oct; 45(8):656-67. PubMed ID: 9569932
[TBL] [Abstract][Full Text] [Related]
17. [The International Prognostic Scoring System for primary myelodysplastic syndrome].
Sisková M; Dohnalová A; Neuwirtová R; Pĕnicková J; Karban J; Cmunt E
Sb Lek; 2002; 103(3):333-8. PubMed ID: 12688177
[TBL] [Abstract][Full Text] [Related]
18. Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.
Cazzola M
Int J Hematol; 2000 Aug; 72(2):134-8. PubMed ID: 11039660
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in the classification and treatment of myelodysplastic syndrome].
Borbényi Z; Varga G
Orv Hetil; 2000 May; 141(21):1121-6. PubMed ID: 10876314
[TBL] [Abstract][Full Text] [Related]
20. Supportive care, growth factors, and new therapies in myelodysplastic syndromes.
Hellström-Lindberg E; Malcovati L
Blood Rev; 2008 Mar; 22(2):75-91. PubMed ID: 18068281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
